Discngine Labs: Virtual Reality for Structure-Based Drug Discovery
Ever wondered how Virtual Reality for Drug Design looks like in practice?
In the second session of our Discngine Labs we hosted industry experts Wilian Cortopassi and Dr. Rishi Gupta from Novartis Institutes for BioMedical Research (NIBR) that presented the “NIBR”Verse: the multidimensional space that brings together data and peers from all over the world in a single (virtual) place for effective collaborations in structure-based drug design.
The presentation was followed by the panel discussion on the current and future opportunities of Virtual Reality for Drug Discovery. Steve McCloskey, from the leading VR software company Nanome, chaired the discussion where industry experts and early adopters , Carmine Talarico, Dompe and Marc Baaden, The French National Centre for Scientific Research, shared their thoughts and experiences on the topic. Panelists were:
In this on-demand content you will learn:
What is the concept behind “NIBR”verse for drug discovery
How Virtual Reality can dramatically increase the productivity and efficiency of your research projects
A case study of successful project outcome with Discngine, Nanome and Novartis integrated technologies
The future trends for collaborative drug design